Massage Therapy in Treating Patients With Cancer Pain

Memorial Sloan Kettering Cancer Center (MSK)

Status and phase: Completed; Phase 2

Conditions: Unspecified Adult Solid Tumor, Protocol Specific; Pain

Treatments: Behavioral: questionaire about pain; Other: period of quiet time; Other: visit with a volunteer; Other: massage therapy

Study type: Interventional

Funder types: Other; NIH

Identifiers

NCT00082290

03-046

Details and patient eligibility

About

RATIONALE: Massage therapy may help lessen pain caused by cancer.

PURPOSE: This randomized phase II trial is studying how well massage therapy works in treating patients with cancer pain.

Full description

OBJECTIVES:

• Determine whether the effects of massage therapy in patients with cancer pain are sufficiently promising to warrant a definitive trial.
• Determine the feasibility of a definitive trial.

OUTLINE: This is a randomized, controlled, pilot study. Patients are stratified according to in-patient status (yes vs no) and first baseline pain score ≥ 7 (yes vs no). Patients are randomized to 1 of 3 treatment arms.

• Arm I (massage therapy): Patients receive a light touch ("Reiki") massage over 45 minutes.
• Arm II (volunteer visit control): Patients receive a 45-minute visit from a trained volunteer who will be available to sit quietly or talk with the patient to discuss issues of concern, as desired by the patient. Volunteers will not touch the patient except to pat their shoulder or briefly hold their hand.
• Arm III (quiet time control): Patients receive 45 minutes of quiet time. Pain and mood are assessed at baseline, immediately after treatment, at 6 hours and 24 hours after treatment, and then daily for the next 5 days after treatment.

PROJECTED ACCRUAL: A total of 60 patients will be accrued for this study.

Enrollment: 92 patients

Sex: All

Ages: 18 to 120 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

DISEASE CHARACTERISTICS:

• Diagnosis of cancer

• Baseline pain score ≥ 2 on a 0-10 rating scale where 0 = no pain

• Pain syndrome must be the result of cancer and/or cancer treatment

  • No postoperative or other acute procedural pain

PATIENT CHARACTERISTICS:

• Not specified

PRIOR CONCURRENT THERAPY:

• Concurrent pharmacologic pain therapy allowed

Trial design

Primary purpose: Supportive Care

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

92 participants in 3 patient groups

a massage

Experimental group

Description:

About 45 minute massage

Treatment:

Other: massage therapy

Behavioral: questionaire about pain

visit with a volunteer

Experimental group

Description:

45 minute visit

Treatment:

Other: visit with a volunteer

Behavioral: questionaire about pain

period of quiet time

Experimental group

Description:

45 minutes of quiet time

Treatment:

Other: period of quiet time

Behavioral: questionaire about pain